Literature DB >> 9692410

Planned vaginal delivery versus elective caesarean section: a study of 705 singleton term breech presentations.

O Irion1, P Hirsbrunner Almagbaly, A Morabia.   

Abstract

OBJECTIVE: To compare neonatal mortality and neonatal and maternal morbidity in planned vaginal delivery versus elective caesarean section for breech presentation at term. To identify factors associated with the risk of caesarean section during labour.
DESIGN: Cohort study.
SETTING: University Hospital of Geneva. POPULATION: Seven hundred and five consecutive singleton term breech presentations: 385 planned vaginal deliveries and 320 elective caesarean sections.
METHODS: Relative risk and risk difference with their 95% confidence intervals (95% CI) were calculated for neonatal and maternal morbidity. Prognostic factors for the risk of intrapartum caesarean section were analysed by multiple logistic regression. MAIN OUTCOME MEASURES: 1. Neonatal mortality 2. Neonatal morbidity (eg. fracture, haematoma with hyperbilirubinemia, paresis, paralysis, visceral trauma, respiratory distress, umbilical cord arterial pH < 7.0 with 5 minute Apgar score < 7), corrected neonatal morbidity was defined as morbidity after exclusion of major malformations. 3. Maternal morbidity (eg. endometritis, urinary infection, pulmonary infection, surgical complications, hysterectomy, anaemia, pulmonary embolism, cardio-respiratory arrest).
RESULTS: There were significantly fewer maternal complications in the planned vaginal delivery group than in the elective caesarean section group (risk difference 10.5%, 95% CI 3.9 to 17.0). Five neonates with major malformations died. There was no difference in corrected neonatal morbidity between the planned vaginal delivery and the elective caesarean section groups (risk difference 1.9%, 95% CI -1.0 to 4.9). Nulliparity, maternal age > 30 years and a higher body mass index were independently associated with the risk (30%) of intrapartum caesarean section, but it was not possible to construct a predictive model useful for clinical practice.
CONCLUSIONS: There is no firm evidence to recommend systematic elective caesarean section for breech presentation at term. Large unbiased studies are needed to determine whether a potential benefit for the newborns outweighs the increased risk for the mothers associated with elective caesarean section.

Entities:  

Mesh:

Year:  1998        PMID: 9692410     DOI: 10.1111/j.1471-0528.1998.tb10200.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  6 in total

Review 1.  Inappropriate use of randomised trials to evaluate complex phenomena: case study of vaginal breech delivery.

Authors:  Andrew Kotaska
Journal:  BMJ       Date:  2004-10-30

Review 2.  Reducing stillbirths: interventions during labour.

Authors:  Gary L Darmstadt; Mohammad Yawar Yakoob; Rachel A Haws; Esme V Menezes; Tanya Soomro; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

3.  Comparison of Apgar scores in breech presentations between vaginal and cesarean delivery.

Authors:  Jonny Karunia Fajar; Mohd Andalas; Harapan Harapan
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Jan-Mar

4.  Turning Foetal Breech Presentation at 32-35 Weeks of Gestational Age by Acupuncture and Moxibustion.

Authors:  Paolo Brici; Giovanna Franconi; Cristina Scatassa; Elisabetta Fabbri; Paolo Assirelli
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-09       Impact factor: 2.629

5.  Moxibustion and other acupuncture point stimulation methods to treat breech presentation: a systematic review of clinical trials.

Authors:  Xun Li; Jun Hu; Xiaoyi Wang; Huirui Zhang; Jianping Liu
Journal:  Chin Med       Date:  2009-02-27       Impact factor: 5.455

Review 6.  Effectiveness and Safety of Acupuncture and Moxibustion in Pregnant Women with Noncephalic Presentation: An Overview of Systematic Reviews.

Authors:  Maite Miranda-Garcia; Cristina Domingo Gómez; Cristina Molinet-Coll; Betina Nishishinya; Ikram Allaoui; M Dolores Gómez Roig; Josefina Goberna-Tricas
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-03       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.